Annual Shareholders Equity
$107.60 M
-$21.12 M-16.41%
31 December 2023
Summary:
Eliem Therapeutics annual stockholders equity is currently $107.60 million, with the most recent change of -$21.12 million (-16.41%) on 31 December 2023. During the last 3 years, it has risen by +$86.03 million (+398.88%). ELYM annual shareholders equity is now -35.65% below its all-time high of $167.20 million, reached on 31 December 2021.ELYM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$218.78 M
-$3.50 M-1.58%
30 September 2024
Summary:
Eliem Therapeutics quarterly stockholders equity is currently $218.78 million, with the most recent change of -$3.50 million (-1.58%) on 30 September 2024. Over the past year, it has increased by +$109.03 million (+99.35%). ELYM quarterly shareholders equity is now -1.58% below its all-time high of $222.28 million, reached on 30 June 2024.ELYM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.4% | +99.3% |
| 3 y3 years | +398.9% | +23.8% |
| 5 y5 years | - | - |
ELYM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.6% | +398.9% | -1.6% | +105.7% |
| 5 y | 5 years | -35.6% | +422.0% | -1.6% | +914.4% |
| alltime | all time | -35.6% | +422.0% | -1.6% | +914.4% |
Eliem Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $218.78 M(-1.6%) |
| June 2024 | - | $222.28 M(+108.9%) |
| Mar 2024 | - | $106.38 M(-1.1%) |
| Dec 2023 | $107.60 M(-16.4%) | $107.60 M(-2.0%) |
| Sept 2023 | - | $109.74 M(-2.5%) |
| June 2023 | - | $112.50 M(-3.7%) |
| Mar 2023 | - | $116.86 M(-9.2%) |
| Dec 2022 | $128.72 M | $128.72 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $134.36 M(-5.5%) |
| June 2022 | - | $142.24 M(-8.3%) |
| Mar 2022 | - | $155.14 M(-7.2%) |
| Dec 2021 | $167.20 M(+675.2%) | $167.20 M(-5.4%) |
| Sept 2021 | - | $176.66 M(+73.3%) |
| June 2021 | - | $101.91 M(+105.4%) |
| Mar 2021 | - | $49.62 M(+130.0%) |
| Dec 2020 | $21.57 M(+4.6%) | $21.57 M |
| Dec 2019 | $20.61 M | - |
FAQ
- What is Eliem Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Eliem Therapeutics?
- What is Eliem Therapeutics annual shareholders equity year-on-year change?
- What is Eliem Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly shareholders equity year-on-year change?
What is Eliem Therapeutics annual stockholders equity?
The current annual shareholders equity of ELYM is $107.60 M
What is the all time high annual shareholders equity for Eliem Therapeutics?
Eliem Therapeutics all-time high annual stockholders equity is $167.20 M
What is Eliem Therapeutics annual shareholders equity year-on-year change?
Over the past year, ELYM annual stockholders equity has changed by -$21.12 M (-16.41%)
What is Eliem Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ELYM is $218.78 M
What is the all time high quarterly shareholders equity for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly stockholders equity is $222.28 M
What is Eliem Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ELYM quarterly stockholders equity has changed by +$109.03 M (+99.35%)